CTSO Earnings & Financial Statements - Cytosorbents Corporation logo

CTSO Earnings & Financial Statements

Cytosorbents Corporation

$5.57
+$1.05(+23.12%)
41
Overall
60
Value
18
Tech
47
Quality
How is this score calculated?
Market Cap
$14.24M
Volume
13.89K
52W Range
$2.84 - $17.00
Target Price
$34.83

CTSO earnings and financial statements: Cytosorbents Corporation's income statement, balance sheet and cash flow statement, annual and quarterly.

CTSO Annual Financial Statements

CTSO income statement
Fiscal year20252024202320222021
Revenue$37.06M$35.59M$31.08M$29.36M$43.17M
Cost of revenue$10.57M$10.71M$9.13M$13.96M$11.05M
Operating income-$14.24M-$16.45M-$31.95M-$31.52M-$22.74M
EBITDA-$4.36M-$19.18M-$27.88M-$30.39M-$21.62M
Net income-$8.20M-$20.72M-$29.25M-$32.81M-$24.56M
EPS (diluted)$-0.13$-0.38$-0.64$-0.75$-0.57
CTSO balance sheet
Fiscal year20252024202320222021
Total assets$44.18M$47.37M$52.96M$63.23M$89.52M
Total liabilities$38.28M$36.27M$29.48M$27.86M$26.94M
Shareholders’ equity$5.90M$11.11M$23.48M$35.37M$62.58M
Cash and equivalents$6.25M$3.28M$14.13M$22.14M$52.14M
Long-term debt$28.57M$26.44M$15.44M$18.14M$13.25M
CTSO cash flow statement
Fiscal year20252024202320222021
Operating cash flow-$12.38M-$14.43M-$21.66M-$28.23M-$14.01M
Capital expenditure-$491.0K-$669.0K-$936.2K-$6.46M-$4.28M
Free cash flow-$12.87M-$15.10M-$22.59M-$34.69M-$18.29M
ABCD
1SymbolPriceChangeVol
2CTSO$5.57+23.1%13.89K
3
4
5
6

Get Cytosorbents Corporation Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.